Novel approach to clearing brain waste shows promise for Alzheimer's
Why it matters: This research offers a new therapeutic target for Alzheimer's, potentially leading to improved memory and learning.
- Jia Li and Jin Su at Guangzhou Medical University are pioneering research into the DDR2 receptor's role in Alzheimer's, building on its known involvement in pulmonary fibrosis.
- DDR2 is found in high abundance in the brain tissue of Alzheimer's patients, despite being rare in healthy human tissue, suggesting its direct involvement in the disease's progression.
- Blocking the DDR2 pathway theoretically reduces amyloid-beta protein production and enhances the brain's waste clearance system, offering a dual mechanism to combat Alzheimer's.
- Experiments in human and non-human primate cells and mouse models indicate that DDR2 regulates cellular dysfunction linked to Alzheimer's symptoms, with three specific cell types increasing DDR2 in their membranes during the disease.
A novel approach targeting the DDR2 receptor, typically studied for lung health, shows promise in clearing toxic Alzheimer's-associated proteins and improving memory in mice. Researchers believe blocking DDR2 could both reduce amyloid-beta production and boost waste clearance, potentially reversing the disease.
